HIV prevention, treatment and access
HIV prevention, treatment and access
New Institute for Health Metrics and Evaluation estimates show global health financing dropped 5% in 2026, following a 12% cut in 2025, as the UK posted the largest absolute reduction …
Ministerial Resolution 929-2026/MINSA updates Peru’s national essential medicines formulary with eight HIV and hepatitis products, including a once-daily pediatric HIV tablet for about 500 children and options for more than …
Mexico’s Cofepris has granted marketing authorization for lenacapavir as twice-yearly injectable pre-exposure prophylaxis against HIV, placing Mexico among a small group of countries with regulatory access to the long-acting prevention …
You must be logged in to post a comment.